Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

Welcome to the Journal of Membrane Biology, a premier publication dedicated to advancing our understanding of the complex roles membranes play in biological systems. Published by Springer, this journal features research articles, reviews, and communications on a broad range of topics related to membrane biology, including biomolecular interactions, transport mechanisms, and physiological responses. With an ISSN of 0022-2631 and E-ISSN 1432-1424, the journal has been a cornerstone in the field since its inception in 1969 and continues to thrive as it looks towards 2024. Ranked in the second quartile (Q2) for Biophysics and Physiology, and third quartile (Q3) in Cell Biology, it showcases impactful research that embodies the spirit of scientific inquiry and innovation. Although currently not an Open Access journal, it remains easily accessible to researchers, professionals, and students eager to delve into the dynamic world of membrane studies. As the understanding of membrane dynamics expands, so does its relevance in areas such as drug development and cellular engineering, making the Journal of Membrane Biology an essential resource for those at the forefront of these critical scientific advancements.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, published by Elsevier Science Ltd, is a prestigious academic journal dedicated to advancing the knowledge and understanding of the intricate relationships between nutrition, metabolism, and cardiovascular health. With an impressive HIndex and a consistent trajectory of high-impact research, this journal occupies a commendable position in the academic landscape, achieving Q1 rankings in both Cardiology and Cardiovascular Medicine, as well as in Nutrition and Dietetics for the year 2023. The journal’s Scopus rankings further solidify its reputation, occupying top percentiles across various categories, making it an essential resource for researchers, healthcare professionals, and students keen on exploring the latest findings in the field. Although it is not an open access journal, readers can access a wealth of knowledge that spans from 1996 to 2024, with articles that cover diverse topics in endocrinology, diabetes, and metabolism. By disseminating groundbreaking research and reviews, NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES aims to foster innovation and evidence-based practices that contribute to improved health outcomes worldwide.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS is a distinguished peer-reviewed journal dedicated to advancing the understanding of the biological roles of prostaglandins, leukotrienes, and essential fatty acids in human health and disease. Published by Elsevier Science Ltd, this journal has been at the forefront of research since its inception in 1988 and continues to serve as a vital resource for researchers, clinicians, and students involved in the fields of biochemistry and cell biology. With its impact factor reflecting a solid academic presence—ranking Q3 in Cell Biology and Q2 in Clinical Biochemistry in 2023—this journal is recognized for its quality contributions, particularly in uncovering the biochemical pathways and clinical implications of these lipid mediators. Though not an open-access journal, it provides various access options to ensure the dissemination of critical findings. As the field evolves, PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS remains a pivotal platform for the exploration and discussion of new methodologies, therapeutic avenues, and biological discoveries that impact patient care and the foundational sciences.

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

PPAR Research, an esteemed journal published by HINDAWI LTD, specializes in the rapidly evolving fields of drug discovery and pharmacology, contributing significantly to the body of research surrounding peroxisome proliferator-activated receptors (PPARs) and their roles in various biochemical processes. With an open access policy implemented since 2006, the journal ensures that its high-quality content is readily available, promoting widespread dissemination of knowledge. Currently ranked in the Q2 category for both Drug Discovery and Medical Pharmacology, it boasts a respectable position within the scientific community, evidenced by its Scopus rankings. PPAR Research serves as an essential resource for researchers, professionals, and students looking to advance their understanding of PPAR biology and its implications in therapeutic development. The journal's commitment to excellence and accessibility makes it a key player in supporting innovative research and critical discussions in the life sciences.